Long Term Follow-up of the VisAbility™ Micro Insert System for Presbyopic Patients

NACompletedINTERVENTIONAL
Enrollment

287

Participants

Timeline

Start Date

December 3, 2018

Primary Completion Date

October 1, 2021

Study Completion Date

October 29, 2021

Conditions
Presbyopia
Interventions
DEVICE

VisAbility™ Micro Insert

No (new) intervention will be administered during the course of this long term follow-up study. Subjects that previously participated in the VIS-2014 clinical trial that had VisAbility™ Micro Inserts surgically implanted in the eye(s) will be followed prospectively.

Trial Locations (13)

11793

South Shore Eye Care LLP, Wantagh

18702

Bucci Laser Vision, Wilkes-Barre

27401

Physicians Protocol, Greensboro

40206

Eye Care Institute, Louisville

43082

Comprehensive EyeCare of Central Ohio, Westerville

46260

Eye Surgeons Of Indiana PC, Indianapolis

55420

Chu Vision Institute, Bloomington

60016

The Midwest Center for Sight, Des Plaines

75242

Key Whitman Eye Center, Dallas

78212

Braverman-Terry-Oei-Eye Associates, San Antonio

92122

Gordon Schanzlin New Vision Institute, San Diego

92868

Coastal Vision, Orange

96814

Aloha Laser Vision, Honolulu

All Listed Sponsors
lead

Refocus Group, Inc.

INDUSTRY

NCT03811249 - Long Term Follow-up of the VisAbility™ Micro Insert System for Presbyopic Patients | Biotech Hunter | Biotech Hunter